Healthcare & Life Sciences

The biohacking boom gets a new tool as QuasarMD expands from facial devices to full-body recovery, targeting a market projected to exceed $100 billion.

A new book reveals why physician marriages are surprisingly stable and what every dual-career couple can learn from their success in balancing love and life.

Midwest grocer Fresh Thyme Market extends key partnerships and affordability programs, reinforcing its commitment to tackling food insecurity and health access.

Formula 1 phenom Ollie Bearman isn't just endorsing IM8 Health; he's investing in it, signaling a major shift in how athletes partner with brands.

As Guardian Pharmacy Services prepares for a key investor conference, it showcases strong growth while its industry faces a looming crisis. Can its model work?

With its Q4 results imminent, the vitamin giant's performance in China and the US will be tested against ambitious goals and shifting global health trends.

The estate of philanthropist Joanna Carson goes to auction, offering a rare look at her curated life through fine art, jewelry, and couture.

Cohen & Co.-backed SPAC joins the hunt for a merger target, highlighting a renewed investor appetite for blank check companies in a maturing market.

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

Lay's emotional 'Last Harvest' was America's top Super Bowl ad, but a new report reveals a huge generational divide, with Gen Z crowning a different winner.

As Perimeter preps its year-end results, investors are watching if its aggressive diversification can overcome operational hurdles and justify its new shape.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

A new Orlando campus offers vital nursing programs, including a new LPN option, to bolster Central Florida's strained healthcare workforce.

DifGen Pharmaceuticals' new FDA-approved generic eye drop is only the second of its kind, promising to increase competition and lower costs for patients.

With results expected to beat guidance, all eyes are on Progyny's upcoming earnings as a key indicator for the rapidly expanding corporate family-building industry.

After a student's tragic death, a Waco school district and a local law firm partnered to provide free booster seats, turning grief into a safety mission.

Texas Athletics and supplement brand Humann partner to turn basketball games into a live lesson on heart health, blending science, sports, and marketing.

With rising diagnoses and an aging workforce, Parkinson's is no longer a retirement issue. Are Canadian companies prepared for this new reality?

A nonprofit's Super Bowl ad with Mike Tyson declared war on processed food. Who's behind the campaign, and can it change how America eats?

Aerospace giant GA Telesis sets a new M&A benchmark, integrating its landing gear unit ahead of schedule, boosting efficiency, and securing market dominance.